Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.

Scott, Julie

Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines. [electronic resource] - Cancer chemotherapy and pharmacology May 2007 - 749-57 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

0344-5704

10.1007/s00280-006-0329-z doi


Antineoplastic Combined Chemotherapy Protocols
Drug Screening Assays, Antitumor
Hexanones--administration & dosage
Humans
Melanoma--drug therapy
Multiple Myeloma--drug therapy
Tumor Cells, Cultured